• Accueil >
  • Publications >
  • Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer

Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer

1 févr. 2018BJU International

DOI : 10.1111/bju.13855

Auteurs

Alice Clément-Zhao, Marie Auvray, Hail Aboudagga, Félix Blanc-Durand, Antoine Angelergues, Yann Alexandre Vano, Florence Mercier, Nader El Awadly, Benjamin Verret, Constance Thibault, Stéphane Oudard